Data from the phase 3 Mandala trial shows that a fixed dose of albuterol and budesonide when met its primary endpoint by demonstrating statistically significant and clinically meaningful reductions in the risk of severe exacerbations compared to albuterol, when used as a rescue medicine. “This represents a paradigm shift in the treatment of asthma. We see this combination treatment, which
The American Cancer Society estimates that in 2022 an estimated 236,740 new cases of lung cancer will be diagnosed and 130,180 deaths will occur from this disease. Lung cancer accounts for almost 25% of all cancer deaths in the US. Most cases occur in individuals who are 65 years or older; however, a very small number of people who are